Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus.

Kleins Lab // Publications // Nov 01 2007

PubMed ID: 17643353

Author(s): Chaturvedi N, Bilous R, Sjolie AK, Klein R; DIRECT Programme Steering Committee. Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus. Contemp Clin Trials. 2007 Nov;28(6):780. Epub 2007 Jun 26. PMID 17643353

Journal: Contemporary Clinical Trials, Volume 28, Issue 6, Nov 2007